Pauline Le Faouder Selected Research

Pain (Aches)

8/2015

Quantification and Potential Functions of Endogenous Agonists of Transient Receptor Potential Channels in Patients With Irritable Bowel Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pauline Le Faouder Research Topics

Disease

4	Inflammation (Inflammations) 08/2023 - 01/2016
3	Hypersensitivity (Allergy) 01/2023 - 08/2015
3	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 12/2018 - 08/2015
2	Infections 01/2021 - 01/2015
2	Colitis 01/2021 - 08/2013
1	Insulin Resistance 10/2023
1	Body Weight (Weight, Body) 10/2023
1	Tuberculosis (Tuberculoses) 08/2023
1	Human Influenza (Influenza) 08/2023
1	Latent Infection 08/2023
1	Aortic Valve Stenosis (Aortic Stenosis) 04/2019
1	Hemorrhage 04/2019
1	Coronary Artery Disease (Coronary Atherosclerosis) 04/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019
1	Abdominal Pain (Pain, Abdominal) 12/2018
1	Constipation 12/2018
1	Hyperalgesia 12/2018
1	Sepsis (Septicemia) 01/2018
1	Thrombosis (Thrombus) 01/2018
1	Visceral Pain 11/2017
1	Neoplasms (Cancer) 01/2017
1	Pain (Aches) 08/2015
1	Melanoma (Melanoma, Malignant) 07/2015
1	Cytomegalovirus Infections (Inclusion Disease) 01/2015
1	Obesity 12/2014
1	Peritonitis 08/2013
1	Ischemia 01/2013

Drug/Important Bio-Agent (IBA)

4	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2018 - 01/2013
3	LipidsIBA 01/2018 - 01/2013
2	OxylipinsIBA 08/2023 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 04/2019 - 12/2018
2	AcidsIBA 12/2018 - 01/2015
2	SphingolipidsIBA 01/2017 - 07/2015
2	15-hydroxy-5,8,11,13-eicosatetraenoic acidIBA 08/2015 - 01/2015
2	EicosanoidsIBA 08/2013 - 01/2013
1	Glucose (Dextrose)FDA LinkGeneric 10/2023
1	VaccinesIBA 08/2023
1	Poly I-CIBA 08/2023
1	CytokinesIBA 08/2023
1	Enterotoxins (Enterotoxin)IBA 08/2023
1	SuperantigensIBA 08/2023
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2023
1	gamma-Aminobutyric Acid (GABA)IBA 01/2023
1	LipopeptidesIBA 01/2023
1	Dextran SulfateIBA 01/2021
1	colibactinIBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2019
1	MJN110IBA 01/2019
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2019
1	5-oxo-6,8,11,14-eicosatetraenoic acidIBA 12/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2018
1	Analgesics (Analgesic Drugs)IBA 11/2017
1	17-hydroxyestrane-3-carbonitrile (ECN)IBA 11/2017
1	CaspasesIBA 01/2017
1	CeramidesIBA 01/2017
1	Transient Receptor Potential ChannelsIBA 08/2015
1	5,6-epoxy-8,11,14-eicosatrienoic acidIBA 08/2015
1	Small Interfering RNA (siRNA)IBA 08/2015
1	13-hydroxy-9,11-octadecadienoic acidIBA 01/2015
1	4-O-carboxymethylascochlorinIBA 01/2015
1	Hydroxyeicosatetraenoic Acids (HETE)IBA 01/2013
1	Leukotriene B4IBA 01/2013
1	prostaglandin E3 (PGE3)IBA 01/2013
1	lipoxin A4IBA 01/2013

Therapy/Procedure

2	Therapeutics 04/2019 - 11/2017
2	Injections 01/2019 - 08/2015
1	Oral Administration 01/2021
1	Transcatheter Aortic Valve Replacement 04/2019
1	Ligation 01/2019
1	Spinal Injections 08/2015
1	Hyperthermic Intraperitoneal Chemotherapy 01/2015